“Lymphocyte Subset Distribution Can Predict the Efficacy of First-Line Treatment in Patients With Non-Hodgkin Lymphoma”. Clinical Medicine and Pharmacology, vol. 3, no. 1, Jan. 2026, https://doi.org/10.70731/1m330584.